Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells 12,337 Shares

Omada Health, Inc. (NASDAQ:OMDAGet Free Report) CFO Steven Cook sold 12,337 shares of the stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $23.09, for a total transaction of $284,861.33. Following the completion of the transaction, the chief financial officer owned 187,209 shares in the company, valued at $4,322,655.81. This represents a 6.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Omada Health Price Performance

Shares of NASDAQ:OMDA traded down $0.02 during trading on Wednesday, hitting $22.98. 1,251,953 shares of the company were exchanged, compared to its average volume of 1,096,319. The firm’s 50 day moving average price is $17.83 and its 200-day moving average price is $15.27. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The stock has a market capitalization of $1.37 billion and a P/E ratio of -85.11.

Omada Health (NASDAQ:OMDAGet Free Report) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The firm had revenue of $78.05 million for the quarter. As a group, equities research analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on OMDA. Barclays raised their price objective on Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. JPMorgan Chase & Co. dropped their price target on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research note on Thursday, March 12th. Finally, Wells Fargo & Company lifted their price target on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Read Our Latest Stock Analysis on Omada Health

Institutional Trading of Omada Health

A number of hedge funds have recently added to or reduced their stakes in OMDA. Quarry LP purchased a new position in shares of Omada Health in the 4th quarter valued at approximately $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health during the fourth quarter worth $32,000. Raymond James Financial Inc. purchased a new position in Omada Health in the 2nd quarter valued at $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health in the 4th quarter valued at $45,000. Finally, Versant Capital Management Inc increased its stake in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after buying an additional 2,283 shares during the period.

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Featured Stories

Insider Buying and Selling by Quarter for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.